Actively hiring
Internet Service Providers
Network Security
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$50M
1 round on record
Latest round
$50M
Series C · Mar 2026 · 7 mo ago
Team
201-500
employees, estimated range
Backers
2
Endeavour Vision, Longitude Capital
The money's age
Fresh money
7 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 3
Raised a round Series C $50M
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series C | Mar 2026 | $50M | — | cityam.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Redefining mitral valve repair with CARLEN — a single-leaflet solution expanding options for TEER-eligible and previously untreatable…

Discover Artax Biopharma's pioneering Nck modulators that restore immune balance without immunosuppression. Learn more about our clinical…

Experience the future of security with Argu AI: real-time alerts, natural conversation with video, and smart reports that keep you in…

Better Imaging Enables Better Research The Geegah Ultrasonic Imager makes fast, high-resolution videos of living samples at the micro and…

About Us Aarki provides an industry leading mobile performance advertising solution powered by great people and technology Aarki was built…

GravitHy awards CAP INGELEC EPC contract for Fos-sur-Mer electrical substation. GravitHy selects Danieli for its 2 million tonnes Direct…
Overview
— Reshaping treatment for Functional Mitral Regurgitation (FMR) Transcatheter Leaflet Restoration (TLR) system is engineered to work in harmony with the native leaflets and the Mitral Valve apparatus to restore the function of the valve while preserving natural blood flow in patients with FMR.
News
Polares Medical: $50 Million Series C Raised To Advance U.S. Expansion Of Structural Heart Device
Polares Medical SA, a clinical-stage structural heart company developing a transcatheter therapy for mitral regurgitation, has raised $50 million in a Series C financing to support the U.S. expansion of its MRace Posterior Leaflet Replacement system follo
Read more
Report
Polares Medical Raises $50 Million Series C to Advance U.S. Expansion of MRace Following Strong Clinical Results
LAUSANNE, Switzerland & PALO ALTO, Calif., March 03, 2026--Polares Medical SA ("Polares"), a clinical-stage structural heart company developing the MRace Posterior Leaflet Replacement (PLR) system for mitral regurgitation (MR), today announced the closing
Read more
Report
Financials
Total raised
$50M
Latest round
Series C
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series C | 2026 | $50M | Details |

Endeavour Vision
Longitude Capital 



